Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease.
about
Inflammatory bowel disease and thrombosisUnfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.Review article: inherited thrombophilia in inflammatory bowel disease.Evaluation of new therapies for inflammatory bowel disease.Key role of mast cells and their major secretory products in inflammatory bowel disease.Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond.Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications.Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report.Effects of low molecular weight heparin on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid-induced colitis.Inflammation and coagulation in inflammatory bowel disease: The clot thickens.Venous thromboembolism with inflammatory bowel diseaseUnfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in ratsInflammatory bowel disease: a paradigm for the link between coagulation and inflammation.Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis.Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.MMX® technology and its applications in gastrointestinal diseases.Heparin: new life for an old drug.A 3.0-kDa low molecular weight heparin promotes gastric ulcer healing in rats.Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.Thromboembolism--an important manifestation of inflammatory bowel disease.
P2860
Q26830337-DC0E2FE4-1075-4FB3-9DBF-90115F0ED3F8Q34448852-5BC5D638-6AF3-4223-985E-30F21AC745DAQ34579752-4BF8BA88-68EF-4D63-8012-52C0C23B2DB5Q35147247-AF3671D6-7CF9-4617-BFCA-F5FA706898A1Q35158989-2863E21E-D549-480B-8D58-CEB971A06824Q35216827-2AF9827A-43D4-4F96-9FE7-6C641C412B42Q35648042-79D4421D-E0DE-4A6B-9D9B-DC6F1E8E6556Q35680595-3B675612-BB72-423E-8330-77892BC77234Q35765113-98618564-D88E-4995-ABFF-80D4717E6C92Q36076384-F749F4A3-D023-4B6B-9948-E0B80A0AD2F1Q36214032-6DB23CA2-6B81-46C4-8FC5-88F2E480DFDCQ36474174-A2731C0A-2363-4CD2-AE12-E5ED57825865Q36652262-8D7A2EF5-A187-455A-A291-126F0A76406BQ37089183-D28AA9CE-10F7-403A-8E3F-C540C67FB29FQ37160876-D0B758AC-70CD-47BE-9BD0-31DB9184B9F1Q37270021-B6DE7D10-BD13-4C7C-9DE4-EBD13F587A2DQ37454573-B2FDD709-89BD-4118-B0DF-D3DE8D4B9983Q37660669-29FDC314-5C9F-435B-B2B2-1CC4706B7B81Q37909074-216FD9E0-C938-4CD5-B971-D8E4C191B245Q38315654-BE37FDE5-C623-4DD5-8814-C5830468B014Q40095211-1A59E4AD-1485-4BAC-AFC3-F520E4E8C64EQ40164066-2A14EBA4-ED2C-4994-AEEB-26DEEC1F21C1Q40764905-1275F06E-A2D5-451E-93C9-DBEB7604C66DQ47339211-2B74D81F-91EC-4BCD-99A5-0F7390EBD3D9Q55039194-91406F82-000A-4EAD-9B6B-1B1F09C3F49E
P2860
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Review article: potential ther ...... in inflammatory bowel disease.
@ast
Review article: potential ther ...... in inflammatory bowel disease.
@en
Review article: potential ther ...... in inflammatory bowel disease.
@nl
type
label
Review article: potential ther ...... in inflammatory bowel disease.
@ast
Review article: potential ther ...... in inflammatory bowel disease.
@en
Review article: potential ther ...... in inflammatory bowel disease.
@nl
prefLabel
Review article: potential ther ...... in inflammatory bowel disease.
@ast
Review article: potential ther ...... in inflammatory bowel disease.
@en
Review article: potential ther ...... in inflammatory bowel disease.
@nl
P2093
P2860
P1476
Review article: potential ther ...... in inflammatory bowel disease.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2000.00860.X
P407
P577
2000-11-01T00:00:00Z